blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2399911

EP2399911 - Polymorphs of Febuxostat [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  18.04.2023
Database last updated on 03.04.2025
Most recent event   Tooltip21.04.2023Revocation of patentpublished on 24.05.2023  [2023/21]
Applicant(s)For all designated states
SANDOZ AG
Lichtstrasse 35
4056 Basel / CH
[2015/34]
Former [2011/52]For all designated states
SANDOZ AG
Lichtstrasse 35
4056 Basel / CH
Inventor(s)01 / Griesser, Ulrich
c/o University of Innsbruck
Institut für Pharmazie
Innrain 52 c
6020 Innsbruck / AT
02 / Adamer, Verena
c/o University of Innsbruck
Institut für Pharmazie
Innrain 52 c
6020 Innsbruck / AT
03 / Hotter, Andreas
c/o Sandoz GmbH
Biochemiestr. 10
6250 Kundl / AT
04 / Langes, Christoph
c/o University of Innsbruck
Institut für Pharmazie
Innrain 52 c
6020 Innsbruck / AT
 [2012/46]
Representative(s)Prüfer & Partner mbB Patentanwälte · Rechtsanwälte
Sohnckestraße 12
81479 München / DE
[N/P]
Former [2012/46]Oser, Andreas
Prüfer & Partner GbR Patentanwälte Sohnckestrasse 12
81479 München / DE
Former [2011/52]Englmeier, Ludwig
Sandoz GmbH Biochemiestraße 10
A-6250 Kundl / AT
Application number, filing date10167344.025.06.2010
[2011/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2399911
Date:28.12.2011
Language:EN
[2011/52]
Type: B1 Patent specification 
No.:EP2399911
Date:19.08.2015
Language:EN
[2015/34]
Search report(s)(Supplementary) European search report - dispatched on:EP28.03.2011
ClassificationIPC:C07D277/56, A61K31/425, A61P19/06
[2011/52]
CPC:
C07D277/56 (EP,US); A61P19/06 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/34]
Former [2011/52]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Polymorphe von Febuxostat[2011/52]
English:Polymorphs of Febuxostat[2011/52]
French:Polymorphes de Febuxostat[2011/52]
Examination procedure03.07.2012Despatch of communication that the application is refused, reason: Examination on filing A.90(5) {1}
18.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time
18.12.2012Amendment by applicant (claims and/or description)
18.12.2012Examination requested  [2013/04]
06.12.2013Despatch of a communication from the examining division (Time limit: M04)
09.04.2014Reply to a communication from the examining division
11.08.2014Despatch of a communication from the examining division (Time limit: M04)
22.12.2014Reply to a communication from the examining division
09.03.2015Communication of intention to grant the patent
11.05.2015Observations by third parties
08.07.2015Fee for grant paid
08.07.2015Fee for publishing/printing paid
08.07.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.12.2013
Opposition(s)Opponent(s)01  18.05.2016  24.05.2016  ADMISSIBLE
Alfred E. Tiefenbacher (GmbH & Co. KG)
Van-der-Smissen-Straße 1
22767 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB, et al, et al
Jungfernstieg 38
20354 Hamburg / DE
 02  18.05.2016  24.05.2016  ADMISSIBLE
Teva Pharmaceutical Industries Ltd
124 Dvora HaNevi'a St.
6944020 Tel Aviv / IL
Opponent's representative
Eder, Michael
Df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Fünf Höfe
Theatinerstrasse 16
80333 München / DE
 [2021/47]
Former [2021/20]
Opponent(s)01  18.05.2016  24.05.2016  ADMISSIBLE
Alfred E. Tiefenbacher (GmbH & Co. KG)
Van-der-Smissen-Straße 1
22767 Hamburg / DE
Opponent's representative
Hamm&Wittkopp Patentanwälte PartmbB, et al, et al
Jungfernstieg 38
20354 Hamburg / DE
 02  18.05.2016  24.05.2016  ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
P.O. Box 3190
49131 Petah Tiqva / IL
Opponent's representative
Eder, Michael
Df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Fünf Höfe
Theatinerstrasse 16
80333 München / DE
Former [2016/26]
Opponent(s)01  18.05.2016  24.05.2016  ADMISSIBLE
Alfred E. Tiefenbacher (GmbH & Co. KG)
Van-der-Smissen-Straße 1
22767 Hamburg / DE
Opponent's representative
Hamm & Wittkopp Patentanwälte PartmbB, et al, et al
Jungfernstieg 38
20354 Hamburg / DE
 02  18.05.2016  24.05.2016  ADMISSIBLE
Teva Pharmaceutical Industries Ltd
5 Basel Street
P.O. Box 3190
49131 Petah Tiqva / IL
Opponent's representative
Eder, Michael
Df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Fünf Höfe
Theatinerstrasse 16
80333 München / DE
27.06.2016Invitation to proprietor to file observations on the notice of opposition
23.12.2016Reply of patent proprietor to notice(s) of opposition
30.01.2018Date of oral proceedings
26.03.2018Despatch of interlocutory decision in opposition
26.03.2018Despatch of minutes of oral proceedings
30.01.2023Legal effect of revocation of patent [2023/21]
18.04.2023Despatch of communication that the patent will be revoked
Appeal following opposition15.05.2018Appeal received No.  T1065/18
06.08.2018Statement of grounds filed
30.01.2023Result of appeal procedure: revocation of the patent
20.04.2023Despatch of the decision of the Board of Appeal
25.04.2018Appeal received No.  T1065/18
06.08.2018Statement of grounds filed
30.01.2023Result of appeal procedure: revocation of the patent
20.04.2023Despatch of the decision of the Board of Appeal
25.05.2018Appeal received No.  T1065/18
26.07.2018Statement of grounds filed
30.01.2023Result of appeal procedure: revocation of the patent
20.04.2023Despatch of the decision of the Board of Appeal
30.01.2023Date of oral proceedings
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the examination fee
18.12.2012Request for further processing filed
18.12.2012Full payment received (date of receipt of payment)
Request granted
18.01.2013Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SM, SK, SI, SE, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
18.12.2012Request for further processing filed
18.12.2012Full payment received (date of receipt of payment)
Request granted
18.01.2013Decision despatched
The application is deemed to be withdrawn due to failure to file the designation of inventor
30.08.2012Request for further processing filed
30.08.2012Full payment received (date of receipt of payment)
Request granted
12.10.2012Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
30.08.2012Request for further processing filed
18.12.2012Full payment received (date of receipt of payment)
Request granted
18.01.2013Decision despatched
Fees paidRenewal fee
24.05.2012Renewal fee patent year 03
10.06.2013Renewal fee patent year 04
31.03.2014Renewal fee patent year 05
10.06.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.06.2010
AL19.08.2015
AT19.08.2015
BE19.08.2015
BG19.08.2015
CY19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
HR19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
MK19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
SM19.08.2015
TR19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
IE25.06.2016
LU25.06.2016
CH30.06.2016
LI30.06.2016
MT30.06.2016
[2018/47]
Former [2018/38]HU25.06.2010
AT19.08.2015
BE19.08.2015
BG19.08.2015
CY19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
HR19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
MK19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
SM19.08.2015
TR19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
IE25.06.2016
LU25.06.2016
CH30.06.2016
LI30.06.2016
MT30.06.2016
Former [2018/32]HU25.06.2010
AT19.08.2015
BE19.08.2015
CY19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
HR19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
MK19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
SM19.08.2015
TR19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
IE25.06.2016
LU25.06.2016
CH30.06.2016
LI30.06.2016
MT30.06.2016
Former [2018/29]HU25.06.2010
AT19.08.2015
BE19.08.2015
CY19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
HR19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
MK19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
SM19.08.2015
TR19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
IE25.06.2016
LU25.06.2016
CH30.06.2016
LI30.06.2016
Former [2018/28]HU25.06.2010
AT19.08.2015
BE19.08.2015
CY19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
HR19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
MK19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
SM19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
IE25.06.2016
CH30.06.2016
LI30.06.2016
Former [2017/24]AT19.08.2015
BE19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
IE25.06.2016
CH30.06.2016
LI30.06.2016
Former [2017/07]AT19.08.2015
BE19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
MC19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2017/03]AT19.08.2015
BE19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2016/36]AT19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
RO19.08.2015
SE19.08.2015
SI19.08.2015
SK19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2016/23]AT19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
RO19.08.2015
SE19.08.2015
SK19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2016/22]AT19.08.2015
CZ19.08.2015
EE19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
SE19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2016/11]AT19.08.2015
FI19.08.2015
LT19.08.2015
LV19.08.2015
SE19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2016/10]FI19.08.2015
LT19.08.2015
LV19.08.2015
SE19.08.2015
NO19.11.2015
GR20.11.2015
IS19.12.2015
PT21.12.2015
Former [2016/09]FI19.08.2015
LT19.08.2015
LV19.08.2015
NO19.11.2015
GR20.11.2015
Former [2016/08]LT19.08.2015
NO19.11.2015
Former [2016/07]LT19.08.2015
Documents cited:Search[XD]EP1020454  (TEIJIN LTD [JP]) [XD] 1-3 * Paragraphs [0011], [0015], [0019], [0036]; claims; figure 2. *;
 [XD]US2005043375  (IWAI MICHIO [JP], et al) [XD] 1-7,12 * Claims 3, 15; paragraphs [0003], [0023-24], [0032], [0051], [0055-57]. *;
 [A]CN101648926  (CSPC OUYI PHARMACEUTICAL CO LT) [A] 1-7,12 * Pages 5-7 and 12, XRPD data. *;
 [L]  - Bernstein, Polymorphism in Molecular Crystals, Oxford, Clarendon Press, (2002), ISBN 0198506058, XP002608621 [L] 1-7,12 * The whole document. Cited as common general knowledge. *
Examination   - Ivanisevic et al.: "Uses of X-Ray Powder Diffraction In the Pharmaceutical Industry" In: Gad (ed.): "Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing", John Wiley & Sons, Inc. pages 1-42, * Indroduced by the applicant with letter of 18.12.2012. *
    - US Pharmacopeia (USP 29), no. 941, chapter "X-Ray Diffraction", 4 pages. * Indroduced by the applicant with letter of 18.12.2012. *
    - CAIRA M R, "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, (19980101), vol. 198, doi:10.1007/3-540-69178-2_5, ISSN 0340-1022, ISBN 978-3-540-36760-4, pages 163 - 208, XP001156954

DOI:   http://dx.doi.org/10.1007/3-540-69178-2_5
by applicantEP1020454
 US7361676
 US2005043375
otherWO2010144685
OppositionEP1020454
 US2005043375
 CN101648926
 WO2010144685
    - "Chapter 4.5: Infrared spectroscopy", Bernstein, Polymorphism in Molecular Crystals, Oxford, (20020000), page 125, ISBN 0198506058, XP002608621
    - IVANISEVIC et al., "Uses of X-Ray Powder Diffraction In the Pharmaceutical Industry", Pharmaceutical Sciences Encyclopedia: Drug Discovery, Develop- ment, and Manufacturing, (20100000), pages 1 - 42, XP055007590

DOI:   http://dx.doi.org/10.1002/9780470571224.pse414
    - "X-Ray Diffraction", US Pharmacopeia, vol. 29, no. 941, pages 1 - 4, XP055290539
    - CAIRA M. R., "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, BERLIN, DE, (19980000), vol. 198, ISSN 0340-1022, ISBN 978-3-540-36760-4, pages 163 - 208, XP001156954

DOI:   http://dx.doi.org/10.1007/3-540-69178-2_5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.